Notable Analyst Rating Changes 01/26: AMLN, PVTB, VLTR, AMAT, SPWRA, NVLS Upgraded; CI, WBD, JCI, GXDX Downgraded
Tweet Send to a Friend
UPGRADES:
Citgroup upgrades Amylin Pharma (NASDAQ: AMLN) from Hold to Buy, and a $27 price target. Click Here for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citgroup upgrades Amylin Pharma (NASDAQ: AMLN) from Hold to Buy, and a $27 price target. Click Here for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
